RegenXBio share price logo

RegenXBio

NASDAQ: RGNX

Small Cap

$6.93

-0.23

(-3.21%)

as on

RegenXBio Stock Performance

as on October 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.88
    $7.18
    downward going graph

    0.72%

    Downside

    3.61%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.46
    $16.19
    downward going graph

    21.28%

    Downside

    133.62%

    Upside

    downward going graph

RegenXBio share price movements today

Previous Close
$7.16
Open
$7.14
Volume
1.1M
Market Cap
$472.7M
Day's Low - High
$6.88 - $7.18
52 Week Low - High
$5.46 - $16.19

RegenXBio Historical Returns

1 Month Return
-15.7 %
3 Month Return
-29.98 %
1 Year Return
-40.96 %
3 Year Return
-58.06 %
5 Year Return
-80.74 %

RegenXBio Stock Fundamentals & Key Indicators

Check RegenXBio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$472.7M

EPS (TTM)

-3.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.89

Industry PE ratio

-6.86

PEG Ratio

0.05

EBITDA

-139.1M

Revenue (TTM)

174.5M

Profit Margin

54.22%

Return On Equity TTM

-220.07%

RegenXBio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RegenXBio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
RegenXBio image
RegenXBio
Buy$472.7M-80.74%-1.8954.22%0.00%
Moderna image
Moderna
Neutral$90.3B-27.05%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$126.4B179.89%28.7886.04%0.00%
Regeneron image
Regeneron
Buy$77.5B43.94%19.0184.86%0.48%

Stock Returns calculator for RegenXBio Stock including INR - Dollar returns

The RegenXBio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

RegenXBio investment value today

Current value as on today

₹63,759

Returns

-₹36,241

(-36.24%)

Returns from RegenXBio Stock

-₹40,921 (-40.92%)

Dollar Impact

₹4,680 (+4.68%)

Analyst Recommendation on RegenXBio Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for RegenXBio. Average target price of $23.58

RegenXBio Share Price Target

Get share price movements and forecasts by analysts on RegenXBio.

What analysts predicted

70.61%UPSIDE

Target Price

$23.58

Current Price

$6.93

Analyzed by

3 Analysts

High

$42

Target

$23.58

Low

$10

RegenXBio target price $23.58, a slight upside of 70.61% compared to current price of $6.93. According to 3 analysts rating.

Indian Investors' Interest in RegenXBio Stock

Search interest for RegenXBio Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-55% versus previous 30 day period

RegenXBio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
15
22
24
21
89
21
29
30
6
108
Gross Profit
7
7
11
14
85
12
-32
24
-4
106
Operating Income
-61
-56
-62
-51
12
-63
-52
-57
-83
29
EBITDA
-57
-48
-54
-37
18
-55
-44
-51
-77
34
Interest Expense
1
0
0
9
8
10
13
12
8
7
Depreciation
4
4
3
4
3
3
3
3
3
3
Income Before Tax
-63
-52
-59
-51
6
-70
-61
-67
-90
22
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-63
-52
-59
-51
6
-70
-61
-67
-90
22
Net Profit Margin
45.83%
34.38%
48.81%
70.22%
96.14%
57.33%
-107.94%
80.46%
-73.22%
99.04%

RegenXBio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
218
35
154
470
112
90
83
170
Gross Profit
8
208
26
118
418
58
53
49
150
Operating Income
-75
88
-148
-119
159
-262
-268
-233
-161
EBITDA
-73
92
-90
-96
177
-244
-239
-198
-133
Interest Expense
-
-
-
0
26
23
6
12
45
Depreciation
2
3
7
8
9
12
17
16
15
Income Before Tax
-73
104
-97
-106
141
-280
-263
-227
-193
Income Tax Expense
0
4
-2
5
13
0
0
-
-
Net Income
-73
99
-94
-111
127
-280
-263
-227
-193
Net Profit Margin
83.56%
95.59%
76.61%
76.89%
88.98%
51.61%
58.76%
59.72%
88.09%

RegenXBio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-63
-52
-59
-51
6
-70
-61
-67
-90
22
Operating Cash Flow
-55
-45
-40
-31
33
-49
-55
-52
-76
-62
Investing Cash Flow
13
0
50
40
44
-140
42
37
70
65
Financing Cash Flow
120
-9
-10
-7
-5
139
-7
-9
-13
17
Change in Cash
78
-55
-1
0
72
-50
-20
-24
-19
21

RegenXBio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
99
-94
-111
127
-280
-263
-227
-193
Operating Cash Flow
-57
104
-107
-54
218
-207
-218
-173
-123
Investing Cash Flow
-4
-279
93
122
-406
-11
190
103
-15
Financing Cash Flow
84
204
8
200
195
-28
-34
92
116
Change in Cash
21
29
-5
268
7
-248
-62
23
-23

Global Institutional Holdings in RegenXBio

Check out the Institutions with significant holdings in RegenXBio.

Funds
Holdings
Fidelity Salem Street Trust
0.81%
Fidelity
0.72%
Delaware Group Equity Funds IV
0.68%
iShares
4.35%
Vanguard
4.28%
See all

RegenXBio News & Key Events

    Insights on RegenXBio

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -90.05M → 22.70M (in $), with an average increase of 496.5% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 6.39M → 108.01M (in $), with an average increase of 94.1% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 809.3% return, outperforming this stock by 848.3%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 173.9% return, outperforming this stock by 230.5%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, RGNX stock has moved down by -11.3%

    About RegenXBio

    REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucopolysaccharidosis type II and type I, respectively; RGX-181, which is in preclinical development for late-infantile neuronal ceroid lipofuscinosis type II disease; RGX-202, undergoing Phase I/II evaluation for Duchenne muscular dystrophy; and RGX-381, at the preclinical stage for addressing the ocular manifestations of CLN2 disease. In addition to its internal programs, REGENXBIO Inc. licenses its NAV Technology Platform to other biotech and pharmaceutical enterprises. It also maintains a collaborative and licensing agreement with Neurimmune AG for the advancement of innovative gene therapies. Founded in 2008, REGENXBIO Inc. maintains its headquarters in Rockville, Maryland.
    OrganisationRegenXBio
    Headquarters9804 Medical Center Drive, Rockville, MD, 20850, US
    IndustryBiotechnology
    CEOCurran Simpson

    Key Management of RegenXBio

    Name

    Title

    Mr. Curran M. Simpson M.S.

    President, CEO & Director

    Mr. Patrick J. Christmas II, J.D.

    Executive VP & Chief Strategy and Legal Officer

    Dr. Stephen Pakola M.D.

    Executive VP & Chief Medical Officer

    Mr. Mitchell Chan M.B.A.

    Executive VP & CFO

    Mr. Craig Malzahn

    Executive VP of Product Development & CTO

    Dr. Olivier Danos Ph.D.

    Executive VP & Chief Scientific Officer

    Dr. Ram Palanki Pharm.D.

    Executive VP & Chief Commercial Officer

    Dr. Jahannaz Dastgir D.O.

    Clinical Development Lead

    FAQs

    What is RegenXBio share price today?

    RegenXBio share price today is $6.93 as on at the close of the market. RegenXBio share today touched a day high of $7.18 and a low of $6.88.

    What is the 52 week high and 52 week low for RegenXBio share?

    RegenXBio share touched a 52 week high of $16.19 on and a 52 week low of $5.46 on . RegenXBio stock price today i.e. is closed at $6.93,which is 57.20% down from its 52 week high and 27.04% up from its 52 week low.

    What is RegenXBio's market capitalisation today?

    RegenXBio market capitalisation is $0.00T as on .

    How to invest in RegenXBio Stock (RGNX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for RegenXBio on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy RegenXBio Stock (RGNX) from India?

    Indian investors can start investing in RegenXBio (RGNX) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.60 in RegenXBio stock (as per the Rupee-Dollar exchange rate as on ). Based on RegenXBio share’s latest price of $6.93 as on October 17, 2026 at 1:29 am IST, you will get 1.4430 shares of RegenXBio. Learn more about fractional shares .

    What are the returns that RegenXBio has given to Indian investors in the last 5 years?

    RegenXBio stock has given -80.74% share price returns and 26.69% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?